TECH

BIO-TECHNE CORP

Healthcare | Mid Cap

$0.49

EPS Forecast

$319.1

Revenue Forecast

Announcing earnings for the quarter ending 2025-06-30 soon
CRSPCrispr Therapeutics AgHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group IncNVAXNovavax IncMRNAModerna IncDNLIDenali Therapeutics IncNBIXNeurocrine Biosciences IncRGENRepligen Corp